Acute effect of caffeine on physical and cognitive performance in individuals with neurological diseases
Abstract
Introduction: Caffeine is an important neuroprotective agent and brain stimulant, potentially contributing to the prevention and delay of progression of neurological diseases. Objective: To analyze the physical and cognitive performance of individuals with neurological diseases with and without caffeine intake. Materials and Methods: This is a pilot crossover study, employing an experimental research design with a quantitative approach and using a single-blind method. The following tests were performed: Timed Up and Go (TUG), Montreal Cognitive Assessment (MoCA), 6-minute Walk Test (6MWT), Romberg balance test, and coordination test. Results: It was observed that acute caffeine intake does not improve physical and cognitive performance in individuals diagnosed with Stroke (ST) and Parkinson's Disease (PD). Conclusion: The data indicate that pre-exercise caffeine intake does not enhance physical and cognitive performance in individuals with ST and PD, as assessed by MoCA, balance and coordination tests, TUG, and 6MWT.
References
-Almajid, R.; Tucker, C.; Wright, W.G.; Vasudevan, E.; Keshner, E. Visual dependence affects the motor behavior of older adults during the Timed Up and Go (TUG) test. Arquivos de Gerontologia e Geriatria. Vol. 87. 2020.
-Biswas, S.; Bagchi, A. Study of the Efects of Nicotine and Cafeine for the Treatment of Parkinson’s Disease. Bioquímica Aplicada e Biotecnologia. Vol. 195. 2023. p. 639 - 654.
-Britto, R.R.; Sousa, L.A.P. Teste de Caminhada de seis minutos uma normatização brasileira. Fisioterapia em Movimento. Vol. 19, Num. 4, 2006. p. 49-54.
-Calvo, J.L.; Fei, X.; Domínguez, R.; Pareja-Galeano, H. Caffeine and Cognitive Functions in Sports: A Systematic Review and Meta-Analysis. Nutrients. Vol. 13. Num. 3. 2021. p. 868.
-Chieng, D.; kistler, P.M. Coffee and tea on cardiovascular disease (CVD) prevention. Trends in Cardiovascular Medicine. Vol. 37. 2021. p. 399 - 405.
-Choo, P.L.; Tou, N.X.; Pang, B.W.J.; Lau, L.K.; Jabbar, K.A.; Seah, W.T.S.; Chen, K.K.; Ng, T.P.; Wee, S.L. Timed Up and Go (TUG) Reference Values and Predictive Cutoffs for Fall Risk and Disability in Singaporean Community-Dwelling Adults: Yishun Cross-Sectional Study and Singapore Longitudinal Aging Study. Vol. 22. Num. 8. 2021. p. 1640-1645.
-Conceição, R.N.S.; Pereira, A.B.C.N.G. Análise Epidemiológica das internações hospitalares de pacientes com doença de Parkinson nos últimos 5 anos nas regiões brasileiras. Revista de Saúde. Vol. 3. Num. 1. 2022. p. 61-66.
-Carneiro, J.G.; Bortolotti, H.; Camata, T.V.; Bigliassi, M.; Kanthack, T.F.D.; Altimari, L.R. Efeito da ingestão de cafeína sobre o desempenho físico e estado de humor de ciclistas. Revista da Educação Física. Vol. 24. 2013. p.279 - 286.
-Maranhão Filho, P.A.; Maranhão, E.T.; Silva, M.M.; Lima, M.A. Repensando o exame neurológico I: avaliação do equilíbrio estático. Arquivos de Neuro-Psiquiatria. Rio de Janeiro. Vol. 69. Num. 6. 2011. p. 954-958.
-Gabbert, C.; König, I.R.; Lüth, T.; Kasten, M.; Grunewald, A.; Klein, C.; Trinh, J. Fatores de estilo de vida e gravidade clínica da doença de Parkinson. Scientific Reports. Vol. 13. Num. 9537. 2023.
-Hodgson, A.B.; Randell, R.K.; Jeukendrup, A.E. The metabolic and performance effects of caffeine compared to coffee during endurance exercise. Plos One. Vol. 8. Num. 4. 2013.
-Kumar, P.M.; Paing, S.S.T.; Li, H.; Pavanni, R.; Yuen, Y.; Zhao, Y.; Tan, E.K. Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson's. Scientific Reports. Vol. 5. Num. 15492. 2015.
-Meira, E.Q.T.; Lima, P.J.; Meira, V.S.; Silva, I.T. Hábitos de vida de idosos com sequelas doenças neurológicas. Anais VI CIEH. Campina Grande. Realize Editora. 2019.
-Montalvo-Alonso, J.J.; Ferragut, C.; Val- Manzano, M.; Valadés, D.; Roberts, J.; Pérez-López, A. Sex Differences in the Ergogenic Response of Acute Caffeine Intake on Muscular Strength, Power and Endurance Performance in Resistance-Trained Individuals: A Randomized Controlled Trial. Nutrients. Vol. 16. Num. 1760. 2024.
-Otsu, A.E. Fisioterapia em Neurologia. Manole. 2012.
-Oliveira, G.G.; Waters, C. Perfil epidemiológico dos pacientes com acidente vascular cerebral isquêmico. Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo. São Paulo. Vol. 66. 2021.
-Walsh, C. How caffeine changed the world. The Harvard Gazette. 2020. Disponível em: https://news.harvard.edu/gazette/story/2020/08/author-michael-pollan-discusses-how-caffeine-changed-the-world/. Acesso em: 02/07/2024.
-Silva, E.S.; Borges, J.W.P.; Moreira, T.M.M.; Rodrigues, M.T.P.; Souza, A.C.C. Prevalência e fatores de risco associados ao acidente vascular cerebral em pessoas com hipertensão arterial: uma análise hierarquizada. Revista de Enfermagem Referência. Vol. 5. Num. 3. 2020.
-Silvestre, J.; Gianoni, R.; Pereira, P. Cafeína e desempenho físico: metabolismo e mecanismos de ação. Revista Brasileira de Fisiologia do Exercício. Vol. 17. Nume. 2. 2018. p. 130-137.
-Smid, J.; Nitrini, R. Propedêutica Neurológica. Medicina Net, 2008. Disponível em: <https://www.medicinanet.com.br/conteudos/revisoes/1189/propedeutica_neurologic a.htm>. Acesso em: /07/2023.
-Socala, K.; Szopa, A.; Serefko, A.; Poleszak, E.; Wlaz, P. Neuroprotective Effects of Coffee Bioactive Compounds: A Review. International Journal of Molecular Sciences. Polônia. Vol. 22. 2021.
-Surma, S.; Oparil, S. Café e Hipertensão Arterial. Current Hypertension Reports. Vol. 23. Num. 38. 2021.
-Voskoboinik, A.; Koh, Y.; Kistler, P. Cardiovascular effects of caffeinated beverages. Trends in Cardiovascular Medicine. Vol. 29. 2019. p. 345 - 350.
-Zmuda, G.G.O.; Soldera, C.L.C.; Jovanov, E.; Bós, A.J.G. Fases do teste Timed Up and Go como preditoras de quedas futuras em idosos da comunidade. Physical Therapy in Movement. Vol. 35. 2022.
Copyright (c) 2025 Natália Sachett, Patrik Nepomuceno

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with work simultaneously licensed under the Creative Commons Attribution License BY-NC which allows the sharing of the work with acknowledgment of the authorship of the work and initial publication in this journal.
- Authors are authorized to enter into additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to post and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this can bring about productive change as well as increase impact and impact. citation of published work (See The Effect of Free Access).